Overview
Pathophysiology of heart disease
Our laboratory is examining the following areas: pathophysiology and prognostic implications of hypertensive cardiac and arterial involvement; etiology, pathophysiology, and prognosis of mitral valve prolapse and the Marfan syndrome; improved methods to detect left ventricular (LV) hypertrophy and dysfunction; effects of obesity, diabetes and renal dysfunction on cardiac structure and function; cardiac effects of antihypertensive and other treatments; physiologic effects of cardiac resynchronization therapy; relations of cardiac and peripheral arterial disease; and three-dimensional echocardiography.
The principal aims of our group's research are to examine critically the above topics using various modalities of ultrasound in combination with other methodologies in clinical and epidemiologic human population samples and in experimental models. On-going projects include:
1. Relations of non-invasively determined arterial structure, stiffness, and atherosclerosis to pathophysiologic variables and cardiac status.
2. Testing the hypothesis that treatment of blood pressure and LDL cholesterol to lower targets than embodied in current guidelines will have beneficial effect on carotid ultrasound measures of atherosclerosis and echocardiographic measures of heart disease, in the Stop Atherosclerosis in Native DiabeticS (SANDS) study.
3. Influence of gender on cardiac and arterial function in clinical and epidemiological populations.
4. Complications and predictors thereof in patients with valvular heart diseases, including mitral valve prolapse.
5. Marfan aortic involvement and the comparative ability of traditional beta-blocker based vs. newer treatment to reduce its progression.
6. Procedures to improve non-invasive determination of LV hypertrophy.
7. Prevalence of cardiac and arterial disease across ethnic groups and the cardiovascular effects of body composition, diabetes and indices of early renal dysfunction.
8. Refining methods for three-dimensional echocardiographic assessment of the mitral valve and left ventricle.
9. Phenotypic inheritance and genetic linkage of cardiac and arterial hypertrophy and dysfunction as well as of discrete atherosclerosic plaques.
Highlights
- 1Journal of the American Heart Association · 2024
- 2Reviews in cardiovascular medicine · 2022
- 3Future cardiology · 2020
Publications
Funding
Active
5 grants- Co-ITowards Personalized Prosthetic Graft Replacement for Genetically Triggered Thoracic Aortic AneurysmsNational Heart, Lung, and Blood Institute · 2023–2028R01HL170570-01
- Co-IHIV, Sleep, Nocturnal Non-dipping, and Cardiovascular Disease: a Tanzanian CohortNational Heart, Lung, and Blood Institute · 2021–2027R01HL160332-01
- Co-ICardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 SurvivorsNational Heart, Lung, and Blood Institute · 2021–2027R01HL159055-01
- Sub-PIStrong Heart Study - Field CenterNational Heart, Lung, and Blood Institute · 2026–2027 · via University of Oklahoma75N92019D00028/75N92026F00001
- Sub-PISTRONG HEART STUDY, Phase VII ProposalNational Heart, Lung, and Blood Institute · 2019–2027 · via University of Oklahoma75N92019D00027
Completed grants (9)
- KPImpact of Aortic Wall Inflammation and Stiffness on Thoracic Aortic Growth in Marfan SyndromeNational Heart, Lung, and Blood Institute · 2017–2023CareerK23HL138299-05
- Co-ICMR Myocardial Tissue Based Prediction of Ischemic MR Revascularization ResponseNational Heart, Lung, and Blood Institute · 2015–2022R01HL128278-05
- KPLeft Atrial AbNormality, ThromboEmbolism, and Race: Novel Risk Factors For StrokeNational Institute of Neurological Disorders and Stroke · 2016–2021R01NS097443-03
- Sub-PIFatty Liver Disease and its Determinants in an American Indian Population; The Strong Heart StudyNational Institute of Diabetes and Digestive and Kidney Diseases · 2016–2020 · via Texas Biomedical Research InstituteR01DK110096-03
- PICVD in American Indians: Imaging and Cardiovascular CenterNational Heart, Lung, and Blood Institute · 2013–2019· 2 renewals
- KPPredictive Value of Inflammation and Arterial Stiffness in Thoracic Aortic AneurysmNational Marfan Foundation · 2015–2018MF 15091403-02
- Sub-PIGenTAC RegistryNational Heart, Lung, and Blood Institute · 2010–2016 · via Research Triangle InstituteHHSN268201000084C
- Sub-PICerebrovascular Disease and its Consequences in the Strong Study CohortNational Heart, Lung, and Blood Institute · 2009–2014 · via University of Washington, TheR01HL093086-05
- PICardiovascular Evaluation for the SHS Phase VNational Heart, Lung, and Blood Institute · 2013–2013
Clinical research
Completed & closed trials (1)
- PIStress-Strain Myocardial Biomechanics in Aortic StenosisWeill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2020)